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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARYPluripotent stem cells must strictly maintain genomic integrity to prevent transmission of mutations. In human induced pluripotent
stem cells (iPSCs), we found that genome surveillance is achieved via two ways, namely, a hypersensitivity to apoptosis and a very
low accumulation of DNA lesions. The low apoptosis threshold was mediated by constitutive p53 expression and amarked upregulation
of proapoptotic p53 target genes of the BCL-2 family, ensuring the efficient iPSC removal upon genotoxic insults. Intriguingly, despite the
elevated apoptosis sensitivity, bothmitochondrial and nuclear DNA lesions induced by genotoxins were less frequent in iPSCs compared
to fibroblasts. Gene profiling identified that mRNA expression of several antioxidant proteins was considerably upregulated in iPSCs.
Knockdown of glutathione peroxidase-2 and depletion of glutathione impaired protection against DNA lesions. Thus, iPSCs ensure
genomic integrity through enhanced apoptosis induction and increased antioxidant defense, contributing to protection against DNA
damage.INTRODUCTION
The generation of human induced pluripotent stem cells
(iPSCs) from adult somatic cells represents an important
advancement in stem cell biology, because of the many
potential applications including patient-specific tissue
replacement, drug screening, and disease modeling (Okita
and Yamanaka, 2011; Robinton and Daley, 2012). In addi-
tion, iPSCs derived from patients of diseases caused by
known mutations can generate valuable in vitro models
for complex disorders, including aging, diabetes, and neu-
rodegeneration. The iPSCs can be generated through forced
expression of a set of transcription factors and share with
embryonic stem cells (ESCs) the same cardinal features of
self-renewal and pluripotency (Takahashi et al., 2007; Yu
et al., 2007; Park et al., 2008).
Pluripotent stem cells have the capacity to differentiate
into almost any cell type in the adult organism. This plurip-
otency, however, requires that, unlike differentiated cells,
stem cells must be endowed with superior DNA mainte-
nance and repair systems to ensure genomic stability over
multiple generations without propagating DNA errors
(Liu et al., 2014). The mechanisms required to maintain
genomic integrity in response to DNA damage, which
could otherwise compromise competency for tissue
renewal, are only poorly understood and have been largely
investigated in ESCs. Human ESCs and iPSCs, for instance,
have an abbreviated cell cycle with a very brief G1 phase,
indicating that mechanisms mediating responses to DNA886 Stem Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authodamagemay differ from those in somatic cells (Momcilovic
et al., 2009, 2010; Filion et al., 2009).
Under physiological conditions, reactive oxygen species
(ROS) generated as by-product of mitochondrial respira-
tion are the major source of DNA damage (Schieber and
Chandel, 2014). DNA lesions in the absence of DNA repair
can lead to cell death, genomic instability, and cancer.
There are two major ways how ESCs could principally
ensure increased genomic integrity. First, mutation fre-
quencies must be suppressed by low levels of DNA damage
accumulation and efficient repair systems. Second, ESCs
that accumulate mutations or DNA damage must be
rapidly eliminated from the stem cell population. Previous
studies suggested that mechanisms of genome surveil-
lance, including DNA repair, are indeed superior in ESCs
(Saretzki et al., 2008; Maynard et al., 2008). It was shown
that murine ESCs possess highly efficient repair mecha-
nisms resulting in a 100-fold lower mutation frequency
compared with embryonic fibroblasts (Cervantes et al.,
2002). In addition, murine and human ESCs are hypersen-
sitive to several DNA-damaging agents and readily undergo
apoptosis (Qin et al., 2007; Roos et al., 2007; Madden et al.,
2011; Liu et al., 2013).
Multiple mechanisms have been described that sensitize
ESCs to DNA damage-induced apoptosis. First, human
ESCs possess unique ROCK-dependent mechanisms in
singularized cells that lead to a myosin-mediated form of
cell blebbing, which rapidly triggers apoptosis upon cell
detachment (Ohgushi et al., 2010). Second, unlikers
differentiated cells, certain human ESC lines have been
found to express a constitutively pre-activated form of
the proapoptotic BCL-2 protein BAX at the Golgi appa-
ratus, which may quickly translocate to the outer mito-
chondrial membrane and initiate execution of the intrinsic
apoptosis pathway upon DNA damage (Dumitru et al.,
2012). Notably, the basal level of pre-activated BAX varies
among different human ESC lines and, for example, is
not detectable in the H1 cell line. Nonetheless, H1 cells
show the typical sensitivity to DNA damage, suggesting
that additional mechanisms might be involved in priming
ESCs for rapid cell death (Liu et al., 2014).
Although the regulation of pluripotency and genomic
stability has been mainly studied in ESCs, very little is
known regarding themechanisms controlling their suscep-
tibility to death stimuli. In the present study, we investi-
gated how human iPSCs react to DNA damage induced
by several genotoxins and proapoptotic stimuli in compar-
ison to fibroblasts. We found that iPSCs are hypersensitive
to agents triggering the mitochondrial death pathway,
which is mediated by the increased expression of several
proapoptotic BCL-2 proteins. In contrast, iPSCs were
largely resistant to death receptor-mediated apoptosis.
Interestingly, despite the increased apoptosis sensitivity
upon DNA damage, iPSCs displayed very low levels of
DNA lesions compared to other cell types under diverse
genotoxic conditions. Moreover, we found that iPSCs har-
bor high glutathione (GSH) levels and strongly express
several GSH-dependent antioxidant enzymes. The com-
bined depletion of GSH and glutathione peroxidase-2
(GPX2) levels was able to impair this iPSC-specific resis-
tance to DNA damage. Thus, our results suggest that
human iPSCs have a superior DNA maintenance response
that is mediated by both an increased antioxidant defense
and an elevated mitochondrial priming and apoptosis in-
duction. These data might have profound implications
for future iPSC-based therapies that are dependent on the
quality of the differentiated cells and their ability to main-
tain an intact genome.RESULTS
Human iPSCs AreHighly Susceptible toMitochondrial
Cell Death
To elucidate the relationship between DNA damage acqui-
sition and apoptosis induction in human iPSCs, we first
investigated the expression of pluripotency markers. Two
iPSC lines that had been generated in our laboratory from
adult skin fibroblasts (Lehle et al., 2014) were analyzed in
more detail. In vitro analysis and morphological assess-
ment showed that both iPSC lines were very similar to
human ESCs and expressed alkaline phosphatase and plu-Stemripotency markers including NANOG, SOX2, TRA1-60,
TRA1-81, and SSEA-4 (Figure S1). Moreover, visual obser-
vation revealed that no significant differentiation had
occurred, even on the colony periphery.
As ROS generated during mitochondrial respiration are
a major source of DNA damage (Schieber and Chandel,
2014), we first employed hydrogen peroxide to compare
the cell death sensitivity of iPSCs and fibroblasts. After
treatment with 500 mM H2O2, apoptotic and necrotic cell
death was determined by fluorescence-activated cell sort-
ing (FACS) measurement of annexin-V/propidium iodide
(PI) staining. As shown Figure 1A, iPSCs were very sensitive
to oxidative damage-induced cell death, whereas fibro-
blasts remained largely viable even after 24 hr of H2O2
treatment. A similar cell-type-specific sensitivity was
observed after exposure to UVC light, a condition known
to induce cell death mainly by oxidative DNA damage.
Whereas iPSCs were already killed after exposure to a low
UVC dose of 5 mJ/cm2, their somatic precursor cells re-
mained viable even after a high-dose UVC treatment of
100 mJ/cm2 (Figure 1B). Furthermore, bleomycin, a geno-
toxic chemotherapeutic drug, efficiently induced cell death
in iPSCs, but not in fibroblasts (Figure 1C).
The increased apoptosis sensitivity of human ESCs was
reported to be selective toDNA-damaging stimuli (Dumitru
et al., 2012). We therefore investigated cell death in
response to non-genotoxic ER stress and applied tunicamy-
cin and thapsigargin, which triggered cell death of iPSCs,
but only weakly compromised the viability of fibroblasts
(Figures 1D and 1E). In addition, brefeldin A, a Golgi com-
plex disassembly agent, induced cell death in iPSCs, but
not in fibroblasts (Figure 1F). Finally, we compared death
receptor-mediated apoptosis in both cell types. Interest-
ingly and in contrast to the previous stimuli, iPSCs
remained largely resistant to FasL- or TRAIL-induced
apoptosis even after prolonged incubation for 72 hr,
whereas a considerable fraction of fibroblasts was already
killed after a short exposure to both death ligands (Figures
1G and 1H). These results demonstrate that iPSCs display a
high and selective apoptosis sensitivity to death stimuli
activating the mitochondrial pathway, whereas they are
largely resistant to death receptor-mediated apoptosis.
iPSCs Display Increased Mitochondrial Priming
To explore the mechanism underlying the low apoptosis
threshold of iPSCs, we investigated the expression of
several apoptosis mediators using qRT-PCR analysis (Fig-
ure 2A). Transcript levels of members of the inhibitor-of-
apoptosis protein family, including XIAP, IAP1, and partic-
ularly IAP2, were considerably reduced in iPSCs compared
to fibroblasts. In addition, iPSCs displayed lower mRNA
expression of several antiapoptotic BCL-2 protein mem-
bers, including BCL2, BCLX, BCLW, and A1. In contrast,Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authors 887
Figure 1. Human iPSCs Are Highly Susceptible to Stress Stimuli Triggering the Mitochondrial Death Pathway
(A–H) The human iPSC lines L1 and L2 and corresponding primary fibroblasts were treated for the indicated time with 500 mM H2O2 (A),
50 mM bleomycin (C), 6 mM tunicamycin (D), 1 mM thapsigargin (E), 1 mM brefeldin A (F), 50 ng/ml TRAIL (G), and 50 ng/ml FasL (H). In
addition, cells were stimulated with the indicated dose of UVC 6 hr prior to cell death analysis (B). Apoptosis and necrosis rates were
measured by annexin-V/PI staining. Results represent means ± SD from three independent experiments. ***p < 0.001.even under basal conditions, TP53 and important proapo-
ptotic BCL-2members, such as BIM andNOXA, were highly
expressed in iPSCs compared to fibroblasts (Figure 2A).
Furthermore, in line with previous cell death experiments,
iPSCs expressed markedly reduced levels of the death
ligand TRAIL as well as several death receptors (Figure 2B).
Since expression of BCL-2 proteins is often regulated by
posttranslational events, we further analyzed protein
expression using western blot analyses that revealed a
high expression of p53 in iPSCs, but not in fibroblasts (Fig-
ure 2C). In addition, the p53-regulated proapoptotic pro-
teins BAK and BIM were strongly expressed in iPSCs
compared to fibroblasts. No significant differences between
both cell types were found for BCL-XL, BID, and BAX,
whereas expression of MCL-1, which is regulated at the
posttranslational level by Nanog (Noh et al., 2012), was
elevated in iPSCs. Altogether, the mRNA and protein
expression analyses indicated that iPSCs reveal an
increased mitochondrial priming that is presumably medi-888 Stem Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authoated by a strong p53 response, resulting in a shift of the
balance of antiapoptotic to proapoptotic BCL-2 proteins.
In contrast, differentiated cells display low mitochondrial
priming, resulting in resistance to DNA-damaging agents
and other drugs activating the mitochondrial death
pathway. Consistently, boosting the priming with the
BH3 mimetic ABT-737 strongly sensitized fibroblasts to
DNA damage-induced apoptosis (Figure 2D).
DNADamage Rates in Genotoxically Stimulated iPSCs
Are Lower Than in Fibroblasts and Increase upon
Differentiation
Previous studies suggested thatmechanisms of genome sur-
veillance, including DNA repair, are superior in ESCs (Sar-
etzki et al., 2008; Maynard et al., 2008). We therefore deter-
mined the accumulation of DNA damage in iPSCs and
fibroblastsusing long-runreal-timePCR-basedDNAdamage
quantification (LORD-Q) analysis, a highly sensitive tech-
nique for the detection of nuclear and mtDNA damagers
Figure 2. Human iPSCs Display Increased Mitochondrial Priming
(A and B) The iPSC lines L1 and L2 were analyzed for mRNA expression of the indicated regulators of the intrinsic (A) and extrinsic (B)
apoptosis pathways relative to L2 fibroblast mRNA levels. GAPDH was used as reference. A representative experiment is shown.
(C) Western blot analysis shows p53 and the indicated members of the BCL-2 family in L2 iPSCs and fibroblasts.
(D) The BH3mimetic BCL-2 inhibitor ABT-737 sensitizes fibroblasts to DNA damage-induced cell death. L2 fibroblasts were treated for 24 hr
in the presence or absence of bleomycin (70 mM) and ABT-737 (25 mM). Apoptosis and necrosis were measured by annexin-V/PI staining.
Results show the mean ± SD from three independent experiments.(Lehle et al., 2014). To prevent apoptosis-mediated DNA
fragmentation and cellular repair processes, we exposed
the cells to UVC light, which induces DNA damage within
a few seconds of treatment. Surprisingly and in contrast to
the strong apoptotic response induced by UVC, accumula-
tion of both nuclear and mtDNA lesions was significantly
lower in iPSCs than infibroblasts (Figure 3A). To verify these
findings, we additionally measured oxidative DNA lesions,
such as cyclobutane pyrimidine dimers and pyrimi-
dine(6-4)pyrimidone photoproducts, using an ELISA,
which confirmed the low accumulation of DNA damage in
iPSCs (Figure 3B). Also, we analyzed mtDNA damage and
the occurrence of 8-hydroxydeoxyguanosine (8-oxo-dG), a
mutagenic DNA lesion, in response to H2O2 treatment,
which also revealed a reduced acquisition of DNA lesions
in iPSCs compared to fibroblasts (Figures 3C and 3D).
We next investigated whether this protection against
DNA damage was maintained during iPSC differentiation.
To induce differentiation, iPSCs were grown in fetal calf
serum (FCS)-containing medium in the absence of FGF2.
When fibroblasts and undifferentiated and differentiatedStemiPSCs were exposed to different H2O2 concentrations,
differentiated iPSCs clearly displayed enhanced DNA dam-
age rates compared to their undifferentiated counterparts
(Figure 3E). Thus, protection of pluripotent cells against
DNA damage is rapidly lost upon differentiation.
Human iPSCs Exhibit Significantly Lower DNA Lesion
Rates Than Most Tumor Cell Lines
Since malignant cells exhibit several features of stem cells,
we wanted to investigate whether the protection against
DNA damage also could be observed in tumor cells. In addi-
tion to iPSCs and fibroblasts, we therefore UVC-irradiated
15 different tumor lines that were mostly derived from
the NCI60 panel. We found that iPSCs exhibited a signifi-
cantly lower DNA damage rate than fibroblasts in all three
investigated genomic loci, namely mtDNA (Figure 4A), the
GAPDH locus (Figure 4B), and the TP53 locus (Figure 4C).
In most tumor cell lines, the levels of nuclear and mtDNA
damage correlated with each other. Moreover, the damage
rate of mtDNA and the two examined nuclear loci was
significantly lower in iPSCs than in most tumor cell lines.Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authors 889
Figure 3. Human iPSCs Are Protected
against Mitochondrial and Nuclear DNA
Damage
(A) The iPSC lines L1 and L2 and corre-
sponding fibroblasts were irradiated with 20
mJ/cm2 UVC light. Immediately after irra-
diation, damage of mitochondrial (mtDNA)
and nuclear DNA (nDNA; GAPDH locus) was
determined by LORD-Q analysis. Results
show mean values ± SD from three inde-
pendent experiments. p = 0.005 (L1
mtDNA), p < 0.001 (L2 mtDNA, L1 nDNA,
and L2 nDNA).
(B) Following UVC irradiation (20 mJ/cm2)
of iPSCs and fibroblasts, DNA samples were
analyzed for cyclobutane pyrimidine dimers
(CPD) and pyrimidine(6-4)pyrimidone pho-
toproducts (6-4PP) by ELISA. Results show
mean values ± SD from three independent
experiments. p < 0.05.
(C) The iPSCs and fibroblasts were exposed
to 5 mM H2O2 for 5 min before mtDNA
damage was measured by LORD-Q analysis.
Results show mean values ± SD, which were
obtained from L1 and L2 iPSCs and the
corresponding fibroblasts in three inde-
pendent experiments. p < 0.002.
(D) The iPSCs and fibroblasts were exposed to 5 mM H2O2 for 5 min before DNA samples were analyzed for 8-oxo-dG lesions. Results show
mean values ± SD, which were obtained from L1 and L2 iPSCs and the corresponding fibroblasts in three independent experiments.
p < 0.001.
(E) L1 fibroblasts, undifferentiated iPSCs, and iPSCs that had been differentiated by 30 days of incubation in the presence of FCS and
absence of FGF2 were treated for 5 min with the indicated concentrations of H2O2. mtDNA damage rates were measured by LORD-Q analysis
and are given as mean ± SD from three independent experiments. Comparison of whole datasets of undifferentiated iPSCs with data of
fibroblasts and differentiated iPSCs resulted in p values of p < 0.001 and p = 0.002, respectively.Thus, during genotoxic exposure, iPSCs acquire less DNA
lesions than parental fibroblasts and cells derived from
various tumor entities.
Human iPSCs Display High GSH Levels and Decreased
Oxidative Stress
Reduced DNA damage could be mediated by increased
expression of DNA repair genes, as previously shown in
ESCs (Saretzki et al., 2008; Maynard et al., 2008). However,
since iPSCs exhibit protection against both nuclear and
mtDNA damage, another explanation could be that there
is less oxidative damage occurring, possibly due to higher
levels of antioxidants. Measurement of the levels of GSH,
the most important cellular antioxidant, indeed revealed
3- to 4-fold increased levels of GSH in iPSCs compared to fi-
broblasts (Figure 5A). To investigate the functional role of
increased GSH levels, we depleted cellular GSH using
dimethyl fumarate (DMF), which is metabolized in a
GSH-dependent manner, and buthionine sulfoximine
(BSO), an irreversible g-glutamylcysteine synthetase inhib-
itor. Combined treatment of iPSCs and fibroblasts with890 Stem Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authoboth agents for 1 hr was sufficient to reduce GSH contents
in both cell types by at least 80%, without inducing cell
death (Figure 5B). When cells were subsequently treated
withH2O2,GSH-depleted fibroblasts exhibited a significant
and strong increase in DNA damage that was partially
reversed by a cell-permeable glutathione O-ethylester
(GSH-OEt) (Figure 5C). Surprisingly, however, only minor
effects of GSH depletion and substitution on DNA lesion
rates were observed in iPSCs (Figure 5C).
To investigate whether the cells had experienced compa-
rable intracellular stress levels, we measured ROS levels us-
ing dihydrorhodamine 123 staining and FACS analysis. As
shown in Figure 5D, both cell types displayed considerable
ROS level increases after H2O2 exposure, which was signif-
icantly boosted by GSH depletion and rescued by GSH O-
ethylester, demonstrating that the experimental setup
was not responsible for the low effect of GSH depletion
on the DNA vulnerability of iPSCs. Notably, the increase
of ROS levels in fibroblasts was 5- to 10-fold higher than
in iPSCs, suggesting that oxidative stress is efficiently pre-
vented in iPSCs.rs
Figure 4. Comparison of DNA Damage Rates in iPSCs, Fibro-
blasts, and Tumor Cell Lines
(A–C) The human iPSC lines L1 and L2, corresponding fibroblasts,
and several human cell lines of different tumor entities were irra-
diated with 10 mJ/cm2 UVC light. Immediately after irradiation,
cells were harvested and mtDNA damage (A) and nDNA damage in
the GAPDH (B) and TP53 locus (C) were quantified using LORD-Q
analysis. P values indicate statistical significance between iPSCs
and fibroblast and tumor cell lines, respectively.High Levels of GPX2 and GSH Protect iPSCs fromDNA
Damage
The previous results indicated that iPSCs exhibit high GSH
levels, butmight possess additional safeguardmechanisms.
We therefore analyzed mRNA expression of several antiox-
idant enzymes in fibroblasts and iPSCs (Figure 6). Our
qRT-PCR analyses revealed that several glutathione S-trans-
ferases (GSTs), which act as antioxidant and detoxifying
enzymes, were upregulated in iPSCs compared to their
somatic precursor cells. Most striking was GSTA2 that was
expressed at more than 80,000-fold higher levels in iPSCs
relative to primary fibroblasts. In addition, iPSCs revealed
a more than 10,000-fold higher expression of GPX2.
Furthermore, several peroxiredoxins, which act as scaven-
gers of H2O2 and organic hydroperoxides, as well as
glutathione reductase were considerably upregulated in
iPSCs, supporting the potent antioxidant status of iPSCs
(Figure 6).StemIn iPSCs the transcript levels of GSTA2 and GPX2
were elevated not only compared to fibroblasts but also
compared to most tumor cell lines (Figure 7A). The sole
exception was observed in HepG2 hepatocellular carci-
noma cells that, as typical for liver cells, expressed not
only increased levels of both enzymes (Figure 7A), but
were also relatively resistant to DNA damage (Figure 4).
To investigate a functional contribution of GSTA2 or
GPX2 to DNA damage protection, we reducedmRNA levels
of both enzymes in iPSCs by small interfering RNA (siRNA)
treatment. However, neither GSTA2 nor GPX2 knockdown
alone led to significant increases of detectable DNAdamage
following H2O2 exposure (Figure 7B). We next combined
GSH depletion with the knockdown of GPX2 or GSTA2 in
iPSCs. In GSH-depleted cells, knockdown of GPX2, but
not of GSTA2, significantly rendered the cells more vulner-
able to DNA damage following H2O2 exposure. Vice versa,
the lentiviral overexpression of GPX2 in fibroblasts was
sufficient to confer increased resistance to DNA damage
(Figure 7C). These results thus indicate that high levels of
GSH and GPX2 mediate DNA damage protection of iPSCs.
In view of the increased expression of several other antiox-
idant mediators as well as the reported abundance of DNA
repair proteins, it is likely that, in addition, further DNA
damage protection mechanisms ensure genomic integrity
of iPSCs.DISCUSSION
Pluripotent stem cells must tightly control the balance be-
tween cell survival and death to prevent unfavorable muta-
tions and to ensure genomic integrity. First, maintenance
of genomic stabilitymust be particularly stringent, because
any genetic alterations in pluripotent stem cells can impair
the functionality of their progeny and compromise tissue
renewal. Pluripotent stem cells bear an enhanced tumori-
genic potential and share several characteristics with can-
cer cells, such as replicative immortality (Ben-David and
Benvenisty, 2011). These properties require a quick and
strong apoptotic response in DNA-damaged cells to pre-
vent an accumulation of mutations that could facilitate
deregulated proliferation or predispose cells to acquire
further mutations associated with cancer development.
It has been shown that ESCs are hypersensitive to DNA
damage and readily undergo apoptosis (Qin et al., 2007;
Madden et al., 2011; Liu et al., 2013), although much less
is known about iPSCs. DNA damage sensitivity in human
ESCs was shown to correlate with a property, termed mito-
chondrial priming, that is determined by the balance be-
tween pro- and antiapoptotic BCL-2 proteins (Liu et al.,
2013). In the present study, we found that, compared
to differentiated fibroblasts, iPSCs exhibit a low apoptosisCell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authors 891
Figure 5. Human iPSCs Have High GSH Levels and Decreased Oxidative Stress
(A) Analysis of total GSH (GSx) levels in iPSCs and fibroblasts. Values show means ± SD from three independent experiments.
(B) Combined treatment of iPSCs and fibroblasts with 100 mM DMF and 100 mM BSO for 1 hr strongly reduces GSH levels. Values show
means ± SD from three independent experiments.
(C) Effect of GSH depletion on H2O2-induced mtDNA damage. GSH-depleted iPSCs and fibroblasts were treated for 5 min with 2 mM H2O2
before mtDNA damage was determined by LORD-Q analysis. GSH depletion significantly increased H2O2-induced mtDNA lesions in fibro-
blasts, but not in iPSCs. Sensitization was partially reversed by supplementation with 2 mM GSH-OEt. Results show means ± SD from three
independent experiments.
(D) Oxidative stress levels in iPSCs and fibroblasts. GSH-depleted, GSH-OEt-supplemented, BSO/DMF-treated, and control cells were
stained with dihydrorhodamine 123 prior to H2O2 exposure (2 mM, 5 min) and analyzed by flow cytometry. ROS levels are shown as values of
normalized mean fluorescence intensity (MFI) from three independent experiments. *p < 0.05, **p < 0.01, ***p < 0.001.threshold. Interestingly, the high apoptosis sensitivity was
restricted to stimuli activating the mitochondrial pathway,
whereas iPSCs were strongly resistant to the extrinsic
apoptosis pathway, presumably by the downregulation of
several death receptors. Unlike human ESCs (Dumitru
et al., 2012), however, the increased sensitivity of iPSCs
was not confined to DNA-damaging stimuli, but also
observed after treatment with ER stress- or Golgi disas-
sembly-inducing agents that also trigger themitochondrial
pathway.
Human ESCs have been reported to maintain BAX in an
active conformation at the Golgi apparatus under basal
conditions (Dumitru et al., 2012), but this mechanism is
unlikely the sole reason of their increased apoptosis sensi-
tivity. In support of this notion is the finding that the H1
ESC line displays the typical apoptosis hypersensitivity,
but lacks expression of active BAX at the Golgi (Dumitru
et al., 2012). Moreover, we found that, also in human
iPSCs, BAX was evenly distributed in the cytosol, but was892 Stem Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authonot localized at the Golgi (Figure S2). Nevertheless, our
results showed that, even under basal conditions, iPSCs
reveal a strong accumulation of p53, a tumor suppressor,
which also acts as a barrier to somatic cell reprogramming
(Tapia and Scho¨ler, 2010). p53 activates the transcription
of multiple genes involved in apoptosis, in particular pro-
apoptotic BCL-2 proteins. Indeed, compared to fibroblasts,
expression of several p53 target genes including BAK, BIM,
and NOXAwas strongly upregulated, indicating that iPSCs
exhibit high mitochondrial priming compared to differen-
tiated cells. Fibroblasts, however, could be sensitized to
DNA damage-induced apoptosis using ABT-737, an inhibi-
tor of antiapoptotic BCL-2 proteins.
In addition to apoptosis, we investigated the occurrence
of DNA lesions in response to genotoxic insults. Using
LORD-Q analyses, a novel sensitive technique to quantify
DNA lesions (Lehle et al., 2014), we found that, despite
their elevated apoptosis sensitivity, iPSCs accumulated
significantly less DNA lesions than differentiatedrs
Figure 6. Increased mRNA Expression
of Antioxidant and Detoxifying Enzymes
in iPSCs
The iPSCs and fibroblasts were screened for
the differential expression of factors
involved in cellular ROS detoxification by
qRT-PCR. mRNA expression in L1 fibroblasts
was set as 1. A representative dataset is
shown. GAPDH, GAPDH glyceraldehyde-3-
phosphate dehydrogenase; ALAS, amino-
levulinate synthase; ACTB, beta-actin; GST,
glutathione S-transferase; MGST, micro-
somal GST; GPX, glutathione peroxidase;
PRDX, peroxiredoxin; CAT, catalase; GSR,
GSH reductase; TXN, thioredoxin; TMX1,
thioredoxin-related transmembrane protein
1; TXNIP, thioredoxin-interacting protein;
SOD, superoxide dismutase.fibroblasts. Also, in response to treatment with H2O2 and
UVC, oxidative nucleotide modifications such as cy-
clobutane pyrimidine dimers, (6-4) photoproducts, and
8-hydroxydeoxyguanosine (8-oxo-dG) were detected less
frequently. Thus, our data are consistent with the hypoth-
esis that pluripotent stem cells have superior DNA mainte-
nance responses. Interestingly, we observed that this DNA
damage protection was rapidly lost during differentiation
of iPSCs.
There are presumably several mechanisms that
contribute to an efficient maintenance of DNA integrity
in pluripotent stem cells, including the prevention of
DNA damage and the removal of DNA lesions. Compared
to differentiated cells, ESCs display a moderate increase
(approximately 2- to 3-fold) in the expression of certain
DNA repair enzymes of the homologous recombination
and non-homologous end-joining pathways, which repair
DNA double-strand breaks (Saretzki et al., 2008). It is inter-
esting to note that a previous study in human ESCs (May-
nard et al., 2008) found decreased levels of oxidative
DNA lesions, such as 8-oxo-dG, which we assessed as an
additional marker of DNA damage in iPSCs. Although the
decreased 8-oxo-dG levels are suggestive of a more efficient
repair of this lesion, the authors did not find elevated activ-
ities of 8-oxoguanine glycosylase, the primary base exci-
sion repair enzyme required for removing this mutagenic
DNA lesion. These results indicate that base excision repair
is presumably not elevated in ESCs, but rather the occur-
rence of oxidative DNA lesions is prevented.
Our study shows that iPSCs are highly proficient in anti-
oxidant defense, which is presumably responsible for the
low frequency of oxidative DNA lesions in both the mito-
chondrial and nuclear genome. Notably, previous non-Stemquantitative proteomic studies revealed an abundant
expression of antioxidant enzymes, in particular several
peroxiredoxins in human ESCs (Baharvand et al., 2006).
Furthermore, ESC cultures generate fewer ROS than most
somatic cell types, because of their lower reliance on
oxidative phosphorylation and limited mitochondrial
biogenesis (Prigione et al., 2010; Armstrong et al., 2010).
Structural analyses of mitochondria in human ESCs
demonstrated an immature network characterized by few
organelles with poorly developed cristae, which however
increase during differentiation (St John et al., 2006; Facu-
cho-Oliveira et al., 2007). Thus, stem cells maintain low
ROS levels not only by high antioxidant activity, but also
by reduced oxygen consumption and low mitochondrial
biogenesis. Our PCR-based LORD-Q method enabled us
to specifically assess not only nuclear but also mtDNA le-
sions. Several lines of evidence suggest that, in particular,
the occurrence of mtDNA lesions must be prevented for
the maintenance of pluripotency. For instance, studies in
a mouse model with high levels of mtDNA mutations due
to a proof-reading defect of DNA polymerase g (mtDNA
mutator mice) established causal relationships among the
accumulation of mtDNA mutations, stem cell exhaustion,
and premature aging (reviewed in Baines et al., 2014).
In our study, we found that the level of GSH, the most
important cellular antioxidant, was elevated up to 4-fold
in iPSCs compared to somatic fibroblasts. In addition, the
mRNA levels of several peroxiredoxins, GSTs, and gluta-
thione reductase were considerably increased. All these
enzymes might be involved in antioxidant defense and
detoxification, a finding reminiscent of the expression of
aldehyde dehydrogenase-1, which is often used as marker
of cancer stem cells (Ginestier et al., 2007).Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authors 893
Figure 7. GPX2 and GSH Contribute to DNA Damage Protection in iPSCs
(A) Transcript levels of GPX2 and GSTA2 in iPSCs, fibroblasts, and cell lines of different tumor entities. The mRNA levels of the two
GSH-dependent enzymes were analyzed by qRT-PCR relative to GAPDH. A representative dataset is shown.
(B) Combined GSH depletion and GPX2 knockdown impair DNA damage protection of iPSCs. L2 iPSCs were incubated with 25 nM GPX2-
specific, GSTA2-specific, or non-targeting (NT) siRNA. After 72 hr, GSx was depleted by the addition of BSO/DMF for 1 hr, followed by
exposure to 2 mM H2O2 for 5 min. (Top) Measurement of mtDNA damage using the LORD-Q assay is shown. Results represent means ± SD of
three independent experiments. *p < 0.05. (Bottom) Confirmation of the GPX2 and GSTA2 knockdown by western blotting is shown.
(C) Overexpression of GPX2 is sufficient to confer increased resistance to DNA damage in fibroblasts. L2 fibroblasts were transduced with
lentiviral vectors for YFP-coupled GPX2 or the YFP control. Then, 48 hr post-infection, cells were treated with 2 mM H2O2 for 5 min. (Top)
Measurement of mtDNA damage by LORD-Q analysis is shown. Results represent means ± SD from three independent experiments.
p = 0.002. (Bottom) Confirmation of GPX2 overexpression by western blotting using an anti-GPX2 antibody is shown.Most notable was our finding that expression of two
GSH-dependent enzymes, GSTA2 and GPX2, was elevated
more than 80,000- and 10,000-fold, respectively, compared
to fibroblasts. We therefore investigated their possible
contribution to the maintenance of genomic integrity.
Our data show that overexpression of GPX2 in fibroblasts
can significantly increase resistance to oxidative stress-
induced DNA damage. Moreover, using RNAi, we found
that knockdown of GPX2, but not GSTA2, could overcome
DNA damage protection in iPSCs. However, combined
depletion of GSH was required for sensitization to DNA
damage, indicating that, in addition to GPX2, further anti-
oxidant mechanisms might be involved in the protection
against DNA damage in iPSCs. This assumption is sup-
ported by our finding that the expression of several antiox-
idant enzymes was strongly increased in iPSCs.894 Stem Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The AuthoAlthough GPX2 is known as a gastrointestinal GSH
peroxidase, it also is expressed in other tissues (Brigelius-
Flohe´ and Kipp, 2012). Interestingly, its expression level
is increased in intestinal crypt stem cells and malignant
epithelial cells, suggesting a role in proliferation and self-
renewal. It also was found that GPX2 overexpression
alleviates the apoptotic response of breast cancer cells to
oxidative stress (Yan and Chen, 2006). TheGPX2 promoter
is activated by the Wnt pathway that is highly active in
iPSCs and ESCs (Kipp et al., 2012). Like many antioxidant
enzymes, GPX2 expression is further controlled by tran-
scription factor NRF2 (Banning et al., 2005), which very
recently has been implicated also in the self-renewal capac-
ity of ESCs (Jang et al., 2014). It is thus conceivable that
the high antioxidant defense of iPSCs is not only involved
in genomic stability, but also required for self-renewal,rs
replicative immortality, and the delay of differentiation of
iPSCs.
In summary, our study brings together two seemingly
separate processes that accompany the function of iPSCs.
Human iPSCs are able to defend their genomic integrity
by maintaining low levels of ROS through a combination
of enhanced removal and limited production of these mol-
ecules. In addition to the endowance with superior DNA
repair systems, iPSCs display high mitochondrial priming
and apoptosis sensitivity, once DNA damage has occurred.
These processes might not only ensure genomic stability
and prevent transmission of mutations to the progeny,
but also might be important for a possible therapeutic
application of iPSCs.EXPERIMENTAL PROCEDURES
Cell Culture
Human iPSCs were generated as described (Takahashi et al., 2007;
Lehle et al., 2014) by transduction of dermal fibroblasts with the
Yamanaka retroviral cocktail, and grownonmitotically inactivated
mouse embryonic fibroblast (MEF) feeder cells in hES medium
containing Knockout DMEM, 20% serum replacement (all from
Life Technologies), 2 mM glutamine, non-essential amino acids,
25 mM2-mercaptoethanol, and 5 ng/ml FGF2 (PeproTech). Human
fibroblasts were cultured in RPMI-1640 supplemented with 10%
FCS, 2 mM glutamine, and 2 mM sodium pyruvate. All other
cell lines were obtained from ATCC and grown in the recommen-
ded media. Culture media were supplemented with penicillin/
streptomycin.Microscopy
For characterization of the iPSCs, cells were stained for the expres-
sion of pluripotency markers, including NANOG, SOX2, TRA1-60,
TRA1-81, and SSEA-4. To this end, cells were fixed with ice-cold
acetone/methanol (1:1) for 5min,washedwith PBS, and incubated
for 1 hr in blocking buffer (4% BSA, 0.05% saponin in PBS) at room
temperature. The primary antibodies (listed in Table S1) were incu-
bated at 4C overnight. After washing the cells thrice in blocking
buffer, the appropriate Alexafluor-coupled secondary antibody
was applied for 1 hr. Cells were washed again in PBS and incubated
afterward in PBS containing 100 ng/ml DAPI for 5 min. Coverslips
were mounted in fluorescence mounting medium and analyzed
using a DMI6000 fluorescence microscope (Leica). Alkaline phos-
phatase activity was determined by the Alkaline Phosphatase
Detection kit (Millipore) after fixation of cells with 4% formalde-
hyde. For detection of active BAX at the Golgi, cells were fixed in
formaldehyde, permeabilized in blocking buffer, and stained
with conformation-specific anti-BAX-NT and the Golgi marker
anti-GM130.Cell Death Analysis
Cells were stimulated with the indicated genotoxic and proapo-
ptotic agents, including bleomycin (Medac), hydrogen peroxide,
thapsigargin, tunicamycin, brefeldin A (all from Sigma), as wellStemas recombinant TRAIL and FasL (both from Enzo Life Sciences). Af-
ter cell harvest using trypsin for differentiated cells and accutase
(Millipore) for iPSCs, supernatants containing dead cells and the
detached cells were combined. Subsequently, cells were stained
with FITC-annexin-V and PI following the instructions of the
manufacturer (BD Biosciences) and analyzed by flow cytometry.
Cells with positive annexin-V but negative PI stainingwere consid-
ered apoptotic, whereas double-positive cells were considered
necrotic.Induction and Detection of DNA Damage
For induction of DNA damage, adherent somatic cells were singu-
larized using trypsin/EDTA. The iPSCs were detached by accutase
in the presence of the ROCK inhibitor Y-27632 (10 mM, Wako
Pure Chemicals Industries) for 10 min at 37C. Then, 13 106 cells
were resuspended in PBS supplemented with 5% FCS (PBS/F). UVC
irradiation was carried out in 100-mm culture dishes and 10 ml
PBS/F using a Stratalinker 2400 (Stratagene). Bleomycin exposure
was carried out in 300 ml PBS/F for 20min. H2O2 treatmentwas per-
formed in 1 ml PBS for 5 min at 37C. Immediately after stimula-
tion, cells were collected by centrifugation and snap-frozen in
liquid nitrogen.
Detection and quantification of DNA damage was performed by
ELISA or LORD-Q analyses as described previously (Lehle et al.,
2014). Briefly, whole-cell DNA was isolated from genotoxin-
exposed and control samples using the DNeasy Blood & Tissue
kit (QIAGEN) and diluted to 10 ng/ml by the addition of suitable
volumes of elution buffer. Subsequently, 5 ml diluted sample
DNAwas added to 15 ml mastermix consisting of 10 ml 23 KAPA2G
Fast Hot Start Polymerase, 1 ml sense and 1 ml antisense primer
(containing each 10 pmol of the respective oligonucleotide),
0.05 ml 203 LightCycler 480 ResoLight Dye (Roche), and 2.95 ml
high-performance liquid chromatography (HPLC)-grade water.
For each analyzed genomic locus, a long DNA damage sensor frag-
ment and a short reference DNA fragment were amplified in two
separate real-time PCR runs (5 min at 95C pre-heating phase fol-
lowed by 50 PCR cycles: 10 s 95C, 10 s 60C, 2:15 min [long frag-
ments] or 1 s [short fragments] at 72C). For nuclear DNA damage
determination, theGAPDH and TP53 loci were analyzed (see Table
S2 for primer sequences). Calculation of detected lesions per 10 kb
was performed as described previously (Lehle et al., 2014). DNA le-
sions such as cyclobutane pyrimidine dimers, (6-4) photoproducts,
and 8-hydroxydeoxyguanosine were measured using ELISA kits
from Cell Biolabs.Western Blot Analyses
Cells were washed in ice-cold PBS and resuspended in 100–200 ml
RIPA buffer supplemented with 13Mini Complete Protease Inhib-
itor cocktail (Roche). Protein concentrations were determined by
the BCA assay and 10–50 mg protein per lane was loaded onto
SDS-PAGE gels. After electrophoresis, proteins were transferred
onto polyvinylidenedifluoride membranes (Amersham Biosci-
ences). Membranes were blocked in PBS containing 4% BSA and
0.05% Tween-20 for 1 hr, followed by an overnight incubation
with the primary antibodies (listed in Table S1) in blocking buffer
at 4C. After washing the membrane thrice in Tris-buffered saline
(TBS)/0.05% Tween, peroxidase-coupled secondary antibodiesCell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authors 895
were applied for 1 hr. Proteins were visualized using enhanced
chemiluminescence (ECL) reagents (Amersham Biosciences).
qRT-PCR
For relative expression analysis, RNA was isolated from cell pellets
using the RNeasy Mini Kit (QIAGEN). After reverse transcription
(Transcriptor First Strand cDNA Synthesis kit, Roche), cDNA levels
were analyzed in a real-time PCR approach. Experiments were car-
ried out in 96- or 384-well plates on a LightCycler 480 II system
(Roche). Per reaction (96-well plates: 20 ml; 384-well plates: 10 ml re-
action), 10ml 23 SYBRGreenmastermix (Fermentas), each10pmol
sense and antisense primer (see Table S3 for primer sequences),
10 ng of sample cDNA, and HPLC-grade water (ad 20 ml) were
used. The real-time PCR program comprised a 5-min heating phase
(95C) followed by 35 to 50 cycles (10 s at 95C, 10 s at 60C, 10 s at
72C). Relative transcript levels were calculated using the 2DDCT
method (Livak and Schmittgen, 2001).Glyceraldehyde dehydroge-
nase (GAPDH), beta-actin (ACTB), and delta-aminolevulinate syn-
thetase 1 (ALAS1) were used as reference genes. Each sample was
analyzed in triplicate and the resulting Cp values were averaged.
Manipulation and Analysis of Cellular GSH Content
Total cellular GSH (GSx; c[GSx] = c[GSH] + 2 3 c[GSSG]) content
was determined as described previously (Tietze, 1969). Briefly,
105 to 106 cells were lysed in ice-cold 1% 5-sulfosiacylic acid.
After 30-min incubation on ice, lysates were centrifuged (10 min,
20,0003 g) and the supernatants were used forGSx determination,
while the pellets were analyzed for protein content by the BCA
assay. Then, 10 ml supernatants were transferred to a 96-well plate
and mixed with 100 ml reaction solution containing 0.64 ml gluta-
thione reductase (Sigma) solution, 400 mMNADPH, 300 mM of the
colorimetric dye 5,50-dithiobis-(2-nitrobenzoic acid), and 2 mM
EDTA in 100mMsodiumphosphate buffer (pH 7.5). Subsequently,
the absorption at 412 nm was followed for 10 to 15 min and the
slopes of the resulting curves were determined. GSx concentra-
tions were calculated using standard curves, normalized for pro-
tein content and expressed as nmol GSx/mg protein. Depletion
of cellular GSx pools was achieved by co-incubation of the cells
with 100 mM DMF (Sigma) and 100 mM BSO (Sigma) for up to
4 hr (Boivin et al., 2011). GSH repletion was performed by co-incu-
bation of cells with BSO/DMF and 2 mM GSH-OEt (Sigma) (Ghor-
eschi et al., 2011).
Determination of ROS Levels
Tomeasure intracellular ROS, 33 105 cells were stained with 1 mM
dihydrorhodamine 123 (Sigma) in PBS for 10 min at 37C. Subse-
quently, cells were pelletized and resuspended in PBS. Stimulation
with 2 mM H2O2 was performed for 5 min at 37
C. After centrifu-
gation, cells were resuspended in PBS/F and analyzed by flow
cytometry.
Gene Knockdown via siRNA
The iPSCs (5 3 105–106) were harvested with accutase supple-
mented with 10 mM ROCK inhibitor Y-27632 as described above.
Subsequently, the protocol ofMa et al. (2010)was followed. Briefly,
cells were resuspended in 100 ml OPTIMEM medium (Invitrogen)
supplemented with 400 nM SMARTpool siRNA (Dharmacon)896 Stem Cell Reports j Vol. 4 j 886–898 j May 12, 2015 j ª2015 The Authoand 5 ml lipofectamine 2000 (Invitrogen). The cell suspension
was incubated for 5 min at 37C, then diluted with 1.5 ml culture
medium and transferred into six-well plates coated with feeder
MEFs. Cells were harvested 72 hr post-transfection and stimulated
with the indicated genotoxic agents.
Overexpression of GPX2 inHumanDermal Fibroblasts
A third-generation lentiviral expression systemwas used to overex-
press YFP-tagged GPX2 and YFP, respectively, in human dermal fi-
broblasts. The lentiviral vectors pLV.YFP and pLV.YFP-GPX2 were
kindly provided by O. Kranenburg (University Medical Center,
Utrecht, the Netherlands) and co-transfected with pMDLg, pRSV-
Rev, and pMD2.G vector constructs (Addgene) into HEK293
cells using jetPEI (Polyplus). Virus was harvested 2 days post-trans-
fection. The fibroblasts were incubated with virus-containing
medium for 24 hr, and infected cells were selected with 5 mg/ml
puromycin 48 hr following infection.
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